. 2023 Oct 20;19(12):1179–1189. doi: 10.1200/OP.23.00210
© 2023 by American Society of Clinical Oncology
Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/
TABLE 3.
Serious Adverse Events by Condition